Virtu Financial LLC Prelude Therapeutics Inc Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$1.69 - $4.37 $22,995 - $59,462
13,607 New
13,607 $58,000
Q1 2023

May 01, 2023
BUY
$4.58 - $7.34 $51,300 - $82,215
11,201 New
11,201 $64,000
Q4 2021

Feb 17, 2022
SELL
$11.89 - $31.74 $94,406 - $252,015
-7,940 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$25.78 - $38.65 $204,693 - $306,881
7,940 New
7,940 $248,000

Others Institutions Holding PRLD

# of Institutions
72
Shares Held
35.7M
Call Options Held
500
Put Options Held
300
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $38.2M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email